Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80
Organisation › Details

Forschungsinstitut für molekulare Pathologie GmbH (IMP, Research Institute for Molecular Pathology)

The Research Institute of Molecular Pathology (IMP) in Vienna is a basic biomedical research institute largely sponsored by Boehringer Ingelheim. With over 200 scientists from 40 countries, the IMP is committed to scientific discovery of fundamental molecular and cellular mechanisms underlying complex biological phenomena. *


Period Start 1997-02-01 existent
  Group Boehringer Ingelheim (Group)
Products Industry pathology
  Industry 2 molecular biology
Region Region Wien (Vienna)
  Country Austria
  Street 7 Dr. Bohr-Gasse
  City 1030 Wien
  Tel +43-1-79730
    Address record changed: 2013-11-15
Basic data Employees n. a.
    * Document for �About Section�: Quantro Therapeutics GmbH. (7/21/20). "Press Release: Quantro Therapeutics Launched with Breakthrough Oncology Drug Discovery Platform". Vienna.
Record changed: 2020-07-22


Picture Kentro Design Corporate and Web Design Berlin 650x65px

More documents for Boehringer Ingelheim (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture [iito] Made Without Love 650x80px

» top